IGF1 and Sepsis: The potential for IGF-1 replacement as a treatment for both the prevention and management of sepsis has been demonstrated in mice where it improved overall survival rates through enhanced hepatic bacterial clearance [84] and in rats as a cognitive therapeutic when administered within 6 h of septic encephalopathy [85].